Latest news with #2025InducementPlan
Yahoo
19-05-2025
- Business
- Yahoo
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement equity award to a new employee, pursuant to the Company's 2025 Inducement Plan, as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity award was granted to one new employee on May 19, 2025, and consisted of a non-statutory stock option to purchase up to an aggregate of 120,000 shares of common stock of the Company. The option has an exercise price of $1.27 per share, which is equal to the closing price per share of the Company's common stock as reported by The Nasdaq Global Market on May 19, 2025. In addition, the option has a ten-year term and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the employee's start date and the remainder of the shares underlying the option vesting in 36 equal monthly installments thereafter, subject to the employee's continued service with the Company through the applicable vesting dates. The inducement grant is subject to the terms and conditions of an award agreement and the Company's 2025 Inducement Plan. About Climb Bio, Inc. Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit Investors and MediaCarlo Tanzi, Investor Relationsctanzi@ in to access your portfolio
Yahoo
21-03-2025
- Business
- Yahoo
European Wax Center, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PLANO, Texas, March 21, 2025 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ) (the 'Company' or 'European Wax Center'), the leading franchisor and operator of out-of-home waxing services in the United States, announced that on March 21, 2025, and in connection with the previously announced appointment of Katie Mullen as the Company's Chief Commercial Officer, the Company's Board of Directors approved grants of (i) restricted stock units ('RSUs') covering 160,000 shares of the Company's Class A common stock (the 'Mullen RSUs'), (ii) non-qualified stock option awards to purchase 220,000 shares of the Company's Class A common stock with an exercise price of $3.99, which is equal to the closing price of the Company's Class A common stock on the Nasdaq Stock Market on March 21, 2025, (iii) non-qualified stock option awards to purchase 180,000 shares of the Company's Class A common stock with an exercise price of $9.00, and (iv) non-qualified stock option awards to purchase 180,000 shares of the Company's Class A common stock with an exercise price of $12.00 ((ii), (iii) and (iv) collectively, the 'Mullen Options'). The Mullen RSUs and Mullen Options were granted pursuant to the Company's 2025 Inducement Plan. The Mullen RSUs will vest in equal installments on each of the first four anniversaries of January 28, 2025, and the Mullen Options will vest in full on the fourth anniversary of January 28, 2025, in each case subject to Ms. Mullen's continued employment with the Company on each such date. The Mullen RSUs and Mullen Options are subject to the terms and conditions of the Company's 2025 Inducement Plan and the terms and conditions of the RSU award agreement and stock option award agreement covering the applicable grant. The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of the Company (or following a bona fide period of non-employment), as an inducement material to such individuals' entering into employment with the Company, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Mullen RSUs and Mullen Options were granted as such inducement material to Ms. Mullen entering into employment with the Company. About European Wax Center, Inc. European Wax Center, Inc. (NASDAQ: EWCZ) is the leading franchisor and operator of out-of-home waxing services in the United States. European Wax Center locations perform more than 23 million services per year, providing guests with an unparalleled, professional personal care experience administered by highly trained wax specialists within the privacy of clean, individual waxing suites. The Company continues to revolutionize the waxing industry with its innovative Comfort Wax® formulated with the highest quality ingredients to make waxing a more efficient and relatively painless experience, along with its collection of proprietary products to help enhance and extend waxing results. By leading with its values – We Care About Each Other, We Do the Right Thing, We Delight Our Guests, and We Have Fun While Being Awesome – the Company is proud to be Certified™ by Great Place to Work®. European Wax Center, Inc. was founded in 2004 and is headquartered in Plano, Texas. Its network, which includes more than 1,000 centers in 45 states, generated sales of $951 million in fiscal 2024. For more information, including how to receive your first wax free, please visit: Investor ContactEuropean Wax Center, Media ContactEdelman SmithfieldJosh Hochberg & Ashna VasaEWCIR@ Zeno GroupSophia
